Catalent (CTLT) Q3 2022 Earnings Call Transcript
CTLT earnings call for the period ending March 31, 2022.
Source: fool.com
Page 8 - Erytech Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Erytech Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Erytech Pharma Today - Breaking & Trending Today
ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Catalent Acquires Erytech Facility in New Jersey
Catalent has acquired from Erytech Pharma its state-of-the-art, commercial-scale cell therapy manufacturing facility in Princeton, N.J., for $44.5 million.
Source: healthcarepackaging.com
Catalent Acquires Erytech Facility in New Jersey
Catalent has acquired from Erytech Pharma its state-of-the-art, commercial-scale cell therapy manufacturing facility in Princeton, N.J., for $44.5 million.
Source: healthcarepackaging.com
Catalent to Acquire Commercial-Scale Cell Therapy Development and Manufacturing Facility in Princeton, New Jersey, from Erytech
Catalent today announced that it has acquired from Erytech Pharma its state-of-the-art, commercial-scale cell therapy manufacturing facility in Princeton, New Jersey , for $44.
Source: medindia.net